Epineuron Technologies Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Sep 17, 2027The maintenance fee for Systems and methods for delivering neuroregenerative therapy (US 10,589,089) comes due Sep 17, 2027. Unpaid by Mar 17, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 8 of 8
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,589,089 | Systems and methods for delivering neuroregenerative therapy In force · USPTO record | In force | USPTO record | |
| US 11,247,045 | Systems and Methods for Delivering Neuroregenerative Therapy In force · High confidence | In force | High confidence | |
| US 12,318,608 | Devices and methods for delivering neuroregenerative therapy In force · USPTO record | In force | USPTO record | |
| US 12,616,832 | Systems and Methods for Delivering Neuroregenerative Therapy In force · High confidence | In force | High confidence | |
| US 11,247,044 | Devices for delivering neuroregenerative therapy In force · USPTO record | In force | USPTO record | |
| US 11,247,043 | Electrode interface devices for delivery of neuroregenerative therapy In force · USPTO record | In force | USPTO record | |
| US 11,364,381 | Methods for delivering neuroregenerative therapy and reducing post-operative and chronic pain In force · USPTO record | In force | USPTO record | |
| US 12,611,538 | Electrode Interface Devices for Delivery of Neuroregenerative Therapy In force · Medium confidence | In force | Medium confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
3 pending · 1 no status recorded
Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.
| Application | Title | Filed | Status |
|---|---|---|---|
| 19/268,811 | Nerve Locator Devices | Jul 14, 2025 | Pending |
| 19/268,618 | Nerve Locator Devices | Jul 14, 2025 | Pending |
| 19/225,530 | Devices and Methods for Delivering Neuroregenerative Therapy | Jun 2, 2025 | Pending |
| 17/842,650 | Jun 16, 2022 | No status recorded |